Molecule intelOpportunity: Strong0

Sterile Ceftriaxone

5 brands · 3 companies · product forms

Opportunity snapshot

Launch attractiveness
51
Market saturation
8
Price room
97
Regulatory risk
0
5
brands
3
companies
Rs 313.93
median price
11
price points
4.86x
price spread
90
confidence %

Who competes here

Top companies by brand count — concentrated market · leader share 60%

3 brands · 60%
1 brands · 20%

Price room

Across observed sources and strengths
CheapestRs 128.25
MedianRs 313.93
Most expensiveRs 623.22
Spread4.86×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.86x across 11 trusted points (Rs 128.25-623.22). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 1 live product for Sterile Ceftriaxone — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(97) + 20% low-competition(92) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

3 canonical companies and 5 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.86x across 11 trusted points (Rs 128.25-623.22). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.